↓ Skip to main content

Dove Medical Press

Article Metrics

A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease, in healthy…

Overview of attention for article published in Drug Design, Development and Therapy, March 2019
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
36 Mendeley
Title
<p>A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson&rsquo;s disease, in healthy volunteers</p>
Published in
Drug Design, Development and Therapy, March 2019
DOI 10.2147/dddt.s198753
Authors

Wonsuk Shin, Kyoung Soo Lim, Min-Kyoung Kim, Hyun Sook Kim, Jihwa Hong, Stanford Jhee, Joseph Kim, Sungeun Yoo, Yeon-Tae Chung, Jae Moon Lee, Doo-Yeoun Cho

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 36 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 25%
Student > Bachelor 5 14%
Student > Ph. D. Student 5 14%
Librarian 1 3%
Student > Doctoral Student 1 3%
Other 1 3%
Unknown 14 39%
Readers by discipline Count As %
Medicine and Dentistry 7 19%
Neuroscience 3 8%
Nursing and Health Professions 3 8%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Psychology 2 6%
Other 3 8%
Unknown 16 44%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2019.
All research outputs
#12,933,273
of 14,669,073 outputs
Outputs from Drug Design, Development and Therapy
#1,081
of 1,517 outputs
Outputs of similar age
#224,169
of 265,951 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 1 outputs
Altmetric has tracked 14,669,073 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,517 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,951 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them